Are incentives necessary to achieve trial diversity? Two researchers say yes
Pharma companies and even Congress have made efforts over the last year to ensure clinical trials are more representative of the patients they serve …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
